Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals
Laura Gatti(Fondazione IRCCS Istituto Neurologico Carlo Besta), Paola Perego(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 30
Related Papers
Understanding the Pathophysiology of Cerebral Amyloid Angiopathy
|International Journal of Molecular Sciences|2020|86
Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma
|Frontiers in Cell and Developmental Biology|2022|35
Curcumin and Related Compounds in Cancer Cells: New Avenues for Old Molecules
|Frontiers in Pharmacology|2022|33